Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Epilepsia Partialis Continua

Below is an extended Epilepsia Partialis Continua patents listing. Click here to return to the Epilepsia Partialis Continua main in depth entry.

Patents :

US Patent No.Title
6815534 Tissue plasminogen activator-like protease
7041803 Galectin 11
7078186 Apoptosis related polynucleotides, polypeptides, and antibodies
7091315 Protein HDPBQ71
7141547 Albumin fusion proteins comprising GLP-1 polypeptides
7163797 50 human secreted proteins
7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10
7189690 Albumin fusion proteins
7196164 Secreted protein HHTLF25
7205139 Tissue plasminogen activator-like protease
7232667 Keratinocyte growth factor-2 polynucleotides
7026447 53 human secreted proteins
6994857 Albumin fusion proteins
6991789 Methods of modulating intracellular degradation rates of toxins
6824993 Antibodies that bind human prostate specific G-protein receptor HPRAJ70
6878806 Human secreted protein HTEEB42
6905688 Albumin fusion proteins
6919433 Antibodies to protein HPMBQ91
6926898 Albumin fusion proteins
6936688 Human chemokine beta-10 mutant polypeptides
6936691 Secreted protein HCE3C63
6946134 Albumin fusion proteins
6951924 Antibodies against secreted protein HTEBYII
6979437 Pulmonary delivery in treating disorders of the central nervous system
7235529 Brain-associated inhibitor of tissue-type plasminogen activator
7238667 Albumin fusion proteins
7483747 Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
7501123 Human G-protein chemokine receptor (CCR5) HDGNR10
7507413 Albumin fusion proteins
7507414 Albumin fusion proteins
7521424 Albumin fusion proteins
7565199 Methods for treating and/or collecting information regarding neurological disorders, including language disorders
7565200 Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
7569384 Albumin fusion proteins
7577481 Methods and apparatus for effectuating a lasting change in a neural-function of a patient
7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
7482013 Albumin fusion proteins
7459531 50 Human secreted proteins
7446176 12 human secreted proteins
7299096 System and method for treating Parkinson's Disease and other movement disorders
7302298 Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography
7353064 Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7381800 Antibodies to HBIMF63 polypeptide
7390637 Keratinocyte derived interferon
7393934 Human G-protein chemokine receptor (CCR5) HDGNR10
7411051 Antibodies to HDPPA04 polypeptide
7437196 Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
7592010 Albumin fusion proteins

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.